| Product Code: ETC6736666 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Arthritis Therapeutics Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Arthritis Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 China Arthritis Therapeutics Market - Industry Life Cycle |
3.4 China Arthritis Therapeutics Market - Porter's Five Forces |
3.5 China Arthritis Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Arthritis Therapeutics Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 China Arthritis Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 China Arthritis Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of arthritis in China |
4.2.2 Rising geriatric population in China |
4.2.3 Growing awareness about arthritis treatment options in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for arthritis therapeutics in China |
4.3.2 High cost of arthritis treatment options |
4.3.3 Limited access to advanced arthritis therapies in certain regions of China |
5 China Arthritis Therapeutics Market Trends |
6 China Arthritis Therapeutics Market, By Types |
6.1 China Arthritis Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Arthritis Therapeutics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Arthritis Therapeutics Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.1.4 China Arthritis Therapeutics Market Revenues & Volume, By Osteoarthritis, 2021- 2031F |
6.1.5 China Arthritis Therapeutics Market Revenues & Volume, By Psoriatic Arthritis, 2021- 2031F |
6.1.6 China Arthritis Therapeutics Market Revenues & Volume, By Gout, 2021- 2031F |
6.1.7 China Arthritis Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Arthritis Therapeutics Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 China Arthritis Therapeutics Market Revenues & Volume, By TNF Inhibitors, 2021- 2031F |
6.2.3 China Arthritis Therapeutics Market Revenues & Volume, By Interleukin Inhibitors, 2021- 2031F |
6.2.4 China Arthritis Therapeutics Market Revenues & Volume, By NSAIDs, 2021- 2031F |
6.2.5 China Arthritis Therapeutics Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.2.6 China Arthritis Therapeutics Market Revenues & Volume, By Xanthine Oxidase Inhibitors, 2021- 2031F |
6.2.7 China Arthritis Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Arthritis Therapeutics Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 China Arthritis Therapeutics Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 China Arthritis Therapeutics Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 China Arthritis Therapeutics Market Revenues & Volume, By Topical, 2021- 2031F |
7 China Arthritis Therapeutics Market Import-Export Trade Statistics |
7.1 China Arthritis Therapeutics Market Export to Major Countries |
7.2 China Arthritis Therapeutics Market Imports from Major Countries |
8 China Arthritis Therapeutics Market Key Performance Indicators |
8.1 Average time to market approval for arthritis therapeutics in China |
8.2 Number of clinical trials conducted for arthritis treatments in the country |
8.3 Adoption rate of new arthritis therapies in different regions of China |
9 China Arthritis Therapeutics Market - Opportunity Assessment |
9.1 China Arthritis Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Arthritis Therapeutics Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 China Arthritis Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 China Arthritis Therapeutics Market - Competitive Landscape |
10.1 China Arthritis Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 China Arthritis Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here